Financial statements Amgen Biotechnologia
Cash flow statement of Amgen Biotechnologia
Company age:
Age:
14 y. 2 m. 8 d.
Share capital:
Share capital:
5 000 PLN
Cash inflows of AMGEN BIOTECHNOLOGIA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | - | - | - | - | - | 2 344 524,47 |
| Net cash flow from investing activities | - | - | - | - | - | -17 321 765,29 |
| Net cash flow from financial activities | - | - | - | - | - | - |
| Total net cash flow | - | - | - | - | - | -14 977 240,82 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.